Li Yu - May 18, 2021 Form 3 Insider Report for OncoCyte Corp (OCX)

Role
VP Cntrllr/Prncpl Acctng Offcr
Signature
/s/ Li Yu
Stock symbol
OCX
Transactions as of
May 18, 2021
Transactions value $
$0
Form type
3
Date filed
5/24/2021, 07:19 PM
Next filing
Oct 14, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCX Restricted Stock Units May 18, 2021 Common Stock 25K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units shall vest upon the completion of one year of continuous service from the date of grant.
F2 Grant of restricted stock units under the OncoCyte 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock.